Late luteal phase dysphoric disorder in young women



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Rivera-Tovar, A. D.
	Articles by Frank, E.
	Search for Related Content



	PubMed Citation
	Articles by Rivera-Tovar, A. D.
	Articles by Frank, E.

Am J Psychiatry 1990; 147:1634-1636
Copyright © 1990 by American Psychiatric Association

REGULAR ARTICLES

Late luteal phase dysphoric disorder in young women

AD Rivera-Tovar and E Frank
Department of Psychiatry, University of Pittsburgh School of Medicine, PA.

The authors determined the prevalence of late luteal phase dysphoric disorder in 217 university women aged 17-29 years. Unaware of the focus on premenstrual syndrome (PMS), the participants rated DSM-III-R symptoms of late luteal phase dysphoric disorder over 90 days. Using a 30% or greater premenstrual change as an index of luteal variation, the authors found that 10 women (4.6%) met the symptom criteria during two menstrual cycles. Compared to 25 young women seeking treatment for PMS who met the same diagnostic criteria, the 10 women from the university sample reported significantly less fatigue and impaired concentration and somewhat less severe depression and overall symptoms.

This article has been cited by other articles:

The ESHRE Capri Workshop Group
Noncontraceptive health benefits of combined oral contraception
Hum. Reprod. Update, September 1, 2005; 11(5): 513 - 525.
[Abstract] [Full Text] [PDF]

L. S. Cohen, C. N. Soares, K. A. Yonkers, K. M. Bellew, I. M. Bridges, and M. Steiner
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: A Double-Blind, Placebo-Controlled Trial
Psychosom Med, September 1, 2004; 66(5): 707 - 713.
[Abstract] [Full Text] [PDF]

L. S. Cohen, C. Miner, E. Brown, E. W. Freeman, U. Halbreich, K. Sundell, and S. McCray
Premenstrual Daily Fluoxetine for Premenstrual Dysphoric Disorder: A Placebo-Controlled, Clinical Trial Using Computerized Diaries
Obstet. Gynecol., September 1, 2002; 100(3): 435 - 444.
[Abstract] [Full Text] [PDF]

M. Altemus, C. Roca, E. Galliven, C. Romanos, and P. Deuster
Increased Vasopressin and Adrenocorticotropin Responses to Stress in the Midluteal Phase of the Menstrual Cycle
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2525 - 2530.
[Abstract] [Full Text] [PDF]

C. N. Epperson, K. L. Wisner, and B. Yamamoto
Gonadal Steroids in the Treatment of Mood Disorders
Psychosom Med, September 1, 1999; 61(5): 676 - 697.
[Abstract] [Full Text] [PDF]

K. S. Kendler, L. M. Karkowski, L. A. Corey, and M. C. Neale
Longitudinal Population-Based Twin Study of Retrospectively Reported Premenstrual Symptoms and Lifetime Major Depression
Am J Psychiatry, September 1, 1998; 155(9): 1234 - 1240.
[Abstract] [Full Text]

M. Steiner, S. Steinberg, D. Stewart, D. Carter, C. Berger, R. Reid, D. Grover, D. Streiner, and The Canadian Fluoxetine/Premenstrual Dysphoria Col
Fluoxetine in the Treatment of Premenstrual Dysphoria
N. Engl. J. Med., June 8, 1995; 332(23): 1529 - 1534.
[Abstract] [Full Text] [PDF]

Get information about faster international access.